Building on a legacy of innovation that spans more than half a century, Los Angeles
Biomedical Research Institute (LA BioMed) at Harbor-UCLA Medical Center is one of
the country's leading nonprofit biomedical research institutes.
LA BioMed is committed to finding practical, inexpensive solutions to real-world health
problems. Our organization has been serving the citizens of Los Angeles for over 60
years with pioneering and innovative research that led to countless diagnostics, devices
and therapies.
It is often said that “someday they will find a way.” When it comes
to discovery science that drives medical breakthroughs, “they” are
here at LA BioMed and “someday” is today.
Our ability to impact and improve global health through local discoveries
is only proportional to the generosity of others. We thank you for support
and we ask that you continue to help us make ‘someday’ happen today.


About Us

LA BioMed is a non-profit scientific research organization dedicated to saving lives not only in the greater Los Angeles metro area but throughout the world. The organization is located on the Harbor-UCLA Medical Center Campus and affiliated with the David Geffen School of Medicine at UCLA.
Read More

Mission Moment

While no one can be certain of what tomorrow brings, most of us have dreams and plans for the future – especially for our children. That was certainly true for me with my daughter...
Read More


Make a gift through PayPal to the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center by clicking on the Donate button below...

How Ayahuasca Can Revolutionize Psychotherapy

Article from A look at the psychoactive brew that brings users a spiritual payoff for their “work” In a greenhouse at the University of Minnesota, Dennis McKenna walks past the cacao (chocolate) and the Punica (pomegranate), and strides straight to the back...

Man up: Is testosterone an elixir of youth?

 “There’s also a problem that the ‘normal’ ranges for one laboratory may be decidedly different than they are for another laboratory,” says Ronald Swerdloff, chief endocrinologist at Harbor UCLA Medical Center in California and LA Biomed Inv....

FDA accepts Kythera’s ATX-101 new drug application

Kythera Biopharmaceuticals’ new drug application (NDA) for its ATX-101, a submental contouring injectable drug, has been accepted for filing by the US Food and Drug Administration (FDA). According to Kythera Biopharmaceuticals, the ATX-101 NDA will be subject to a standard...

LA Biomed: Project to provide high-quality care for patients with diabetes

Managing diabetes is a year-round challenge for anyone living with the disease. The challenge is even greater for underserved and uninsured people who often don’t have easy access to the care they need to manage their diabetes. Their inability to effectively manage their...

Join the mailing list

Check your email and confirm the subscription